Back to News
Market Impact: 0.15
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
Source: globenewswire.com
Management & GovernanceHealthcare & Biotech
Amy Rock, Ph.D., was appointed Chief Regulatory and Quality Officer. The announcement cites her experience in global regulatory strategy, clinical development, and approvals of novel immunotherapies; no company or financial figures are provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Microsoft offers buyouts to nearly 30% of workforce in ongoing AI shift
- Anthropic’s risk factors include the end of humanity, a feud with the Pentagon, and CEO Dario Amodei’s reputation
- Microsoft offers to buy out a quarter of its workforce
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- Microsoft offers voluntary buyouts to 60,000 employees
- Anthropic's IPO puts power in the hands of founders, giving everyday shareholders little voice
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- AI for Investment Thesis Validation: A Claim-Ledger Method
- Capital Intensity as Gravity: The AI Trade Enters Its Industrial Era (Looking at Q3 2025 Earnings in Tech)